A groundbreaking study reveals a startling truth about weight loss jabs: those who discontinue use regain weight at an alarming rate, surpassing two years. This research, conducted by academics at the University of Oxford and published in the BMJ, analyzed 37 studies involving 9,341 participants. The findings indicate that individuals who cease taking weight loss medications regain weight at a rate of 0.4kg per month, returning to their original weight within an average of 1.7 years. This rapid regain is significantly faster than those on other weight loss plans, highlighting the challenges of maintaining long-term weight loss. The study's lead researcher, Dr. Sam West, emphasizes that this isn't a flaw in the medications but rather a reflection of obesity's chronic nature. He underscores the importance of comprehensive, long-term weight management strategies, cautioning against short-term use without additional support. This research adds to the growing body of evidence suggesting that weight loss drugs can have positive effects on various health aspects, as seen in studies linking them to reduced heart disease risks. However, it also reveals that the benefits of these drugs on cardio-metabolic health markers, such as blood pressure and cholesterol, revert to baseline levels within 1.4 years of discontinuing treatment. While previous studies hinted at rapid weight regain within a year, this study provides the first comprehensive rate of weight regain and estimated time frames for weight and metabolic reversal. The study's findings have significant implications for healthcare systems, with the NHS prescribing Wegovy for up to two years and Mounjaro without a prescription time limit. Experts emphasize the need for appropriate prescribing and tailored support to ensure long-term weight management success. Katharine Jenner, from the Obesity Health Alliance, highlights the role of the food environment in weight regain, advocating for systemic improvements to create a healthier food landscape.
